Eagle Liabilities And Stockholders Equity from 2010 to 2024
| EGRX Stock | USD 3.71 0.02 0.54% |
Liabilities And Stockholders Equity | First Reported 2012-12-31 | Previous Quarter 414.2 M | Current Value 404.8 M | Quarterly Volatility 116.3 M |
Check Eagle Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eagle Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.5 M, Interest Expense of 4.9 M or Selling General Administrative of 118.5 M, as well as many indicators such as Price To Sales Ratio of 1.3, Ptb Ratio of 1.77 or Days Sales Outstanding of 129. Eagle financial statements analysis is a perfect complement when working with Eagle Pharmaceuticals Valuation or Volatility modules.
Eagle | Liabilities And Stockholders Equity |
Latest Eagle Pharmaceuticals' Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of Eagle Pharmaceuticals over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Eagle Pharmaceuticals' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eagle Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
Eagle Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 204,788,264 | |
| Geometric Mean | 105,139,825 | |
| Coefficient Of Variation | 80.69 | |
| Mean Deviation | 133,906,243 | |
| Median | 238,603,000 | |
| Standard Deviation | 165,253,571 | |
| Sample Variance | 27308.7T | |
| Range | 481M | |
| R-Value | 0.96 | |
| Mean Square Error | 2356.9T | |
| R-Squared | 0.92 | |
| Slope | 35,440,257 | |
| Total Sum of Squares | 382322.4T |
Eagle Liabilities And Stockholders Equity History
About Eagle Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Eagle Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Eagle Pharmaceuticals investors use historical funamental indicators, such as Eagle Pharmaceuticals's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Eagle Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Eagle Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eagle Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Eagle Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Eagle Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 467.1 M | 490.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eagle Stock Analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.